China’s Symbow Medical reportedly raised $17 million (¥120 million) for the MR-safe surgical navigation platform it’s developing. Huayi Capital led the investment in the Beijing based company, joined by the Chinese government’s National Emerging Industry Guidance Fund, Shandong Buchang Pharmaceuticals Co. and Sangel Capital, the China Money Network reported, citing a Symbow press release. Symbow […]